All times are listed in CEST (Central European Summer Time)
Displaying One Session
Industry Satellite Symposium
Date
22.09.2020
Chairs
- Neal Shore (Myrtle Beach, United States of America)
AstraZeneca - PARP inhibitors in the treatment of metastatic castrate resistant prostate cancer
Industry Satellite Symposium
Chair’s welcome and introductions (ID 5410)
Speakers
- Neal Shore (Myrtle Beach, United States of America)
AstraZeneca - PARP inhibitors in the treatment of metastatic castrate resistant prostate cancer
Industry Satellite Symposium
Exploring molecular heterogeneity in prostate cancer - prevalence and clinical significance (ID 5411)
Speakers
- Neal Shore (Myrtle Beach, United States of America)
AstraZeneca - PARP inhibitors in the treatment of metastatic castrate resistant prostate cancer
Industry Satellite Symposium
Dissecting the clinical data for PARP inhibitors in metastatic castrate resistant prostate cancer (ID 5412)
Speakers
- Joaquin Mateo (Barcelona, Spain)
AstraZeneca - PARP inhibitors in the treatment of metastatic castrate resistant prostate cancer
Industry Satellite Symposium
Considerations for the approach to HRRm testing in prostate cancer (ID 5413)
Speakers
- Alexander W. Wyatt (Vancouver, Canada)
AstraZeneca - PARP inhibitors in the treatment of metastatic castrate resistant prostate cancer
Industry Satellite Symposium
Panel discussion (ID 5414)
Speakers
- Neal Shore (Myrtle Beach, United States of America)
- Joaquin Mateo (Barcelona, Spain)
- Alexander W. Wyatt (Vancouver, Canada)
AstraZeneca - PARP inhibitors in the treatment of metastatic castrate resistant prostate cancer
Industry Satellite Symposium
Summary and meeting close (ID 5415)
Speakers
- Neal Shore (Myrtle Beach, United States of America)
AstraZeneca - PARP inhibitors in the treatment of metastatic castrate resistant prostate cancer
Industry Satellite Symposium
Live Q&A - 28 September 2020 - 16:45-17:45 (ID 5536)
Speakers
- Neal Shore (Myrtle Beach, United States of America)